Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Sorrento Therpt (SRNE)

7.95 0.4 (5.3%)

05-24 16:00

Open:

7.55

Pre. Close:

7.55

High:

7.95

Low:

7.5

Volume:

1,580,784

Market Cap:

738M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.951 - 7.978

7.978 - 8.004

Low:

7.423 - 7.457

7.457 - 7.489

Close:

7.893 - 7.943

7.943 - 7.989

Technical analysis  (as of: 2018-05-24 5:32:22 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 9.29     One year: 10.85

Support:

Support1: 6.62    Support2: 5.80

Resistance:

Resistance1: 7.95    Resistance2: 9.29

Pivot:

7.30

Moving Averages:

MA(5): 7.40     MA(20): 7.05

MA(100): 6.88     MA(250): 4.04

MACD:

MACD(12,26): 0.29     Signal(12,26,9): 0.24

%K %D:

%K(14,3): 81.25     %D(3): 70.63

RSI:

RSI(14): 65.36

52-Week:

High: 10.65  Low: 1.5  Change(%): 354.3

Average Vol(K):

3-Month: 327688  10-Days 173187

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
SRNE has closed below upper band by 0.6%. Bollinger Bands are 51.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to SRNE's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-17T06:15:01-04:00
Earning A Good, Safe Yield On Your Gold Holdings

2018-04-27T11:27:11-04:00
Celyad up 20% on encouraging data on CAR-T candidate CYAD-01

2018-04-24T13:43:00-04:00
Lifshitz & Miller LLP Announces Investigation of Cancer Genetics, Inc., Colony Northstar, Inc., Pacific Commerce Bancorp, MiMedx Group, Inc., Sorrento Therapeutics, Inc., TrueCar, Inc., and Windstream Holdings, Inc.

2018-04-16T18:50:00-04:00
Cramer's lightning round: Take a long-term view on Spotify

2018-04-15T00:25:16-04:00
Portfolio Review: Continued Market Outperformance In Q1 2018

2018-04-13T00:14:18-04:00
Rounds Report: Geron Rallied While FDA's New Guidance Created Tailwinds For Individualized Medicine Innovators

2018-04-09T12:40:49-04:00
Surface Oncology Proposes IPO Terms

2018-04-06T08:48:58-04:00
Incyte epacadostat flop weighing on certain biotechs premarket

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

92.82

Shares Float (M)

% Held by Insiders

% Held by Institutions

30.20

Shares Short (K)

16543

Shares Short Prior Month (K)

1930

Stock Financials

EPS

-0.450

EPS Est. Current Year

-1.070

EPS Est. Next Year

-0.650

EPS Est. Next Quarter

-0.240

Forward EPS

-0.490

Book Value (p.s.)

3.420

PEG Ratio

-0.26

Profit Margin

23.75

Operating Margin

34.36

Return on Assets (ttm)

2.2

Return on Equity (ttm)

6.5

Qtrly Rev. Growth

407.8

Gross Profit (p.s.)

1.384

Sales Per Share

EBITDA (p.s.)

0.674

Qtrly Earnings Growth

Operating Cash Flow (M)

-99.18

Levered Free Cash Flow (M)

31.43

atoplab.com

Valuation

P/E

-17.67

P/E Growth Ratio

0.05

P/BV

2.32

P/S

338494944.00

P/CF

-7.44

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-08-01

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.